Market data as of Jun 3, 2026
Analysis for Medtronic is being prepared
Our research team is working on a comprehensive fundamental analysis. Check back soon — financial charts and valuation models will appear here.
Detailed Charts
Medtronic Quarterly Performance
Quarterly revenue and net income with a weekly share-price overlay
Upgrade to see the full 5 years (20 quarters) of quarterly data.
How to Read Quarterly Performance
Quarterly revenue and net income are Medtronic's most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.
For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.
Unlock Valuation Analysis
Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.
- Multi-model fair value estimates (P/E, DCF, EPS Growth)
- Undervalued/overvalued assessment with upside potential
- Compare fair values across methodologies
Unlock Full Analysis
Get the complete 10-year financial history with interactive charts and growth analysis.
Related Stocks
Boston Scientific (BSX)
Health Care Equipment
Net income surged 55.7% to $2.89B in FY2025.
Bristol Myers Squibb (BMY)
Pharmaceuticals
CVS Health (CVS)
Health Care Services
Edwards Lifesciences (EW)
Health Care Equipment
HCA Healthcare (HCA)
Health Care Facilities
McKesson Corporation (MCK)
Health Care Distributors